Understanding the EU MDR: What Manufacturers Need to Know in 2025 and Beyond
The European Union Medical Device Regulation (EU MDR 2017/745) has fundamentally transformed how medical devices are brought to market in Europe. Unlike the previous Medical Device Directive (MDD), which allowed manufacturers to self-certify Class I devices and placed greater responsibility on manufacturers for conformity, the MDR introduces stricter requirements for clinical evidence, post-market surveillance, and Notified Body oversight.
The European Union Medical Device Regulation (EU MDR 2017/745) has fundamentally transformed how medical devices are brought to market in Europe. Unlike the previous Medical Device Directive (MDD), which allowed manufacturers to self-certify Class I devices and placed greater responsibility on manufacturers for conformity, the MDR introduces stricter requirements for clinical evidence, post-market surveillance, and Notified Body oversight.
Key Changes Under MDR
For manufacturers accustomed to the MDD framework, the transition to MDR brings several significant changes:
Expanded Classification Rules: Many devices that were previously Class I under MDD are now classified higher under MDR. For example, certain software and reusable surgical instruments now fall under Class Ir or Class Is, requiring Notified Body involvement for sterility and reuse aspects.
Clinical Evaluation Requirements: MDR mandates more robust clinical evidence, including clinical evaluation reports (CER) and post-market clinical follow-up (PMCF) plans. The requirement for equivalence claims has been tightened, making it more difficult to rely solely on predicate device data.
UDI and EUDAMED: Unique Device Identification (UDI) is now mandatory, and registration in EUDAMED is progressively becoming operational. Manufacturers must assign UDI-DI and UDI-PI to their devices and ensure data accuracy.
Person Responsible for Regulatory Compliance (PRRC): Manufacturers must designate a PRRC with specific qualifications and responsibilities, including ensuring conformity with regulatory requirements and reporting obligations.
What This Means for Manufacturers in Pakistan and Beyond
For manufacturers in Pakistan and other emerging markets, MDR compliance requires a strategic approach. The first step is accurate classification of your device under MDR Annex VIII. For Class Is and Class Ir devices, Notified Body involvement is required specifically for the sterility and reuse aspects, while the remaining aspects may be self-certified. For Class IIa and IIb devices, full Notified Body conformity assessment is required.
At Veritas Quality Solutions, we have guided numerous manufacturers through MDR certification, including Class IIa, IIb, and Is devices, in collaboration with Notified Bodies such as SGS Belgium. Our team helps you navigate classification, technical documentation, clinical evaluation, and Notified Body interactions.
Looking Ahead
The MDR landscape continues to evolve. Recent amendments have extended transition timelines for certain legacy devices, and ongoing guidance from the Medical Device Coordination Group (MDCG) continues to clarify requirements. Manufacturers should monitor these developments and ensure their technical documentation remains current.